DK1337529T3 - Heterocyclylalkylpiperidinderivater, deres fremstilling og præparater indeholdende dem - Google Patents

Heterocyclylalkylpiperidinderivater, deres fremstilling og præparater indeholdende dem

Info

Publication number
DK1337529T3
DK1337529T3 DK01996538T DK01996538T DK1337529T3 DK 1337529 T3 DK1337529 T3 DK 1337529T3 DK 01996538 T DK01996538 T DK 01996538T DK 01996538 T DK01996538 T DK 01996538T DK 1337529 T3 DK1337529 T3 DK 1337529T3
Authority
DK
Denmark
Prior art keywords
preparation
preparations containing
heterocyclylalkylpiperidine derivatives
heterocyclylalkylpiperidine
derivatives
Prior art date
Application number
DK01996538T
Other languages
Danish (da)
English (en)
Inventor
Philippe Hubert
Eric Bacqu
Jean-Christophe Carry
Youssef El-Ahmad
Michel Evers
Jean-Luc Malleron
Serge Mignani
Guy Pantel
Michel Tabart
Fabrice Viviani
Original Assignee
Novexel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novexel filed Critical Novexel
Application granted granted Critical
Publication of DK1337529T3 publication Critical patent/DK1337529T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK01996538T 2000-11-15 2001-11-14 Heterocyclylalkylpiperidinderivater, deres fremstilling og præparater indeholdende dem DK1337529T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0014738A FR2816618B1 (fr) 2000-11-15 2000-11-15 Derives heterocyclylalcoyl piperidine, leur preparation et les compositions qui les contiennent

Publications (1)

Publication Number Publication Date
DK1337529T3 true DK1337529T3 (da) 2006-12-18

Family

ID=8856503

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01996538T DK1337529T3 (da) 2000-11-15 2001-11-14 Heterocyclylalkylpiperidinderivater, deres fremstilling og præparater indeholdende dem

Country Status (28)

Country Link
EP (2) EP1695964A1 (sh)
JP (1) JP2004514661A (sh)
KR (1) KR100849608B1 (sh)
CN (1) CN1483031A (sh)
AR (1) AR034006A1 (sh)
AT (1) ATE337311T1 (sh)
AU (2) AU1836502A (sh)
BG (1) BG107793A (sh)
BR (1) BR0115312A (sh)
CA (1) CA2429311A1 (sh)
CZ (1) CZ20031316A3 (sh)
DE (1) DE60122567T2 (sh)
DK (1) DK1337529T3 (sh)
EA (1) EA200300568A1 (sh)
EE (1) EE200300207A (sh)
ES (1) ES2271119T3 (sh)
FR (1) FR2816618B1 (sh)
HR (1) HRP20030379A2 (sh)
HU (1) HUP0303758A3 (sh)
IL (1) IL155841A0 (sh)
NO (2) NO20032187L (sh)
PL (1) PL363004A1 (sh)
PT (1) PT1337529E (sh)
SK (1) SK5822003A3 (sh)
TN (1) TNSN01160A1 (sh)
WO (1) WO2002040474A2 (sh)
YU (1) YU46803A (sh)
ZA (1) ZA200303794B (sh)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030019621A (ko) 2000-07-26 2003-03-06 스미스클라인비이참피이엘시이 항균 활성을 갖는 아미노피페리딘 퀴놀린 및 그의아자이소스테릭 유사체
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0112836D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0118238D0 (en) * 2001-07-26 2001-09-19 Smithkline Beecham Plc Medicaments
AR038240A1 (es) 2002-01-29 2005-01-05 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para su preparacion
JP4508650B2 (ja) 2002-01-29 2010-07-21 グラクソ グループ リミテッド アミノピペリジン化合物、当該化合物の製法および当該化合物を含有する医薬組成物
TW200406413A (en) 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
AR040336A1 (es) 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
FR2842807A1 (fr) 2002-07-23 2004-01-30 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, procede et intermediaires de preparation et compositions les renfermant
GB0217294D0 (en) * 2002-07-25 2002-09-04 Glaxo Group Ltd Medicaments
FR2844270B1 (fr) 2002-09-11 2006-05-19 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent
FR2844268B1 (fr) * 2002-09-11 2004-10-22 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent
DE10256405A1 (de) * 2002-12-02 2004-06-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen, die Topoisomerase IV inhibieren
JP4704755B2 (ja) 2002-11-05 2011-06-22 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー 抗菌剤
ES2312839T3 (es) 2002-12-04 2009-03-01 Glaxo Group Limited Quinolinas y sus derivados nitrogenados y su uso como agentes antibacterianos.
US7232833B2 (en) 2003-03-28 2007-06-19 Novexel 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
FR2852954B1 (fr) * 2003-03-28 2006-07-14 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
FR2862301B1 (fr) * 2003-11-17 2007-12-21 Aventis Pharma Sa Nouveau procede de preparation de quinoleines 3-fluorees
FR2867472B1 (fr) * 2004-03-12 2008-07-18 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
US7709472B2 (en) 2005-01-25 2010-05-04 Glaxo Group Limited Antibacterial agents
WO2006081264A1 (en) 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
EP1846418A4 (en) 2005-01-25 2009-12-23 Glaxo Group Ltd ANTIBACTERIAL ACTIVE SUBSTANCES
EP1846416A4 (en) 2005-01-25 2009-07-01 Glaxo Group Ltd ANTIBACTERIAL AGENTS
JP2008531709A (ja) 2005-03-01 2008-08-14 ワイス シンノリン化合物および肝臓ｘ受容体調節物質としてのそれらの使用
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
CA2635126A1 (en) 2006-01-26 2007-08-02 Actelion Pharmaceuticals Ltd Tetrahydropyrane antibiotics
WO2007115947A1 (en) 2006-04-06 2007-10-18 Glaxo Group Limited Pyrrolo-quinoxalinone derivatives as antibacterials
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
MX2009013254A (es) 2007-06-15 2010-01-25 Actelion Pharmaceuticals Ltd Derivados 3-amino-6(1-amino-etil)-tetrahidropirano.
EP2080761A1 (en) 2008-01-18 2009-07-22 Glaxo Group Limited Compounds
US20110275661A1 (en) 2008-10-17 2011-11-10 Glaxo Group Limited Tricyclic nitrogen compounds used as antibacterials
US8318940B2 (en) 2009-01-15 2012-11-27 Glaxo Group Limited Naphthyridin-2 (1 H)-one compounds useful as antibacterials
US9273001B2 (en) * 2012-08-15 2016-03-01 Glaxo Group Limited Chemical process
MX2017002321A (es) 2014-08-22 2017-08-02 Glaxosmithkline Ip Dev Ltd Compuestos que contienen nitrogeno triciclico para tratar infeccion por neisseria gonorrhoeae.
WO2016138988A1 (en) * 2015-03-02 2016-09-09 University Of Copenhagen Piperazine inhibitors of bacterial gyrase and topoisomerase iv
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7908031A (nl) 1979-11-01 1981-06-01 Acf Chemiefarma Nv Nieuwe chinolinederivaten en farmaceutische preparaten die een dergelijke verbinding bevatten, alsmede werk- wijze voor het bereiden van deze verbindingen.
JPH0239546A (ja) 1988-07-29 1990-02-08 Origin Electric Co Ltd 混成集積回路の製造方法
NZ232091A (en) 1989-01-16 1990-12-21 Bellon Labor Sa Roger 7-fluoro-8-(piperazin-1-yl)-4-oxo-1,4-dihydro-benzo(b)(1,8)naphthyridine-3-carboxylic acid derivatives, preparation and pharmaceutical compositions thereof
WO1999037635A1 (en) * 1998-01-26 1999-07-29 Smithkline Beecham Plc Quinoline derivatives as antibacterials
EP1144404A1 (en) * 1999-01-20 2001-10-17 Smithkline Beecham Plc Piperidinylquinolines as protein tyrosine kinase inhibitors
FR2852954B1 (fr) * 2003-03-28 2006-07-14 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
CA2429311A1 (en) 2002-05-23
ES2271119T3 (es) 2007-04-16
BG107793A (bg) 2004-08-31
DE60122567T2 (de) 2007-08-23
TNSN01160A1 (fr) 2005-11-10
NO20032187D0 (no) 2003-05-14
KR20030060934A (ko) 2003-07-16
CN1483031A (zh) 2004-03-17
AU2002218365B2 (en) 2007-07-05
NO20032187L (no) 2003-06-26
WO2002040474A3 (fr) 2002-10-31
ATE337311T1 (de) 2006-09-15
EA200300568A1 (ru) 2003-12-25
BR0115312A (pt) 2003-09-23
JP2004514661A (ja) 2004-05-20
HRP20030379A2 (en) 2005-04-30
HUP0303758A2 (hu) 2004-03-01
DE60122567D1 (de) 2006-10-05
AU1836502A (en) 2002-05-27
WO2002040474A2 (fr) 2002-05-23
IL155841A0 (en) 2003-12-23
SK5822003A3 (en) 2004-06-08
EP1337529B1 (fr) 2006-08-23
ZA200303794B (en) 2004-06-29
YU46803A (sh) 2006-05-25
EP1695964A1 (fr) 2006-08-30
EE200300207A (et) 2003-08-15
FR2816618A1 (fr) 2002-05-17
KR100849608B1 (ko) 2008-07-31
NO20072142L (no) 2007-04-25
FR2816618B1 (fr) 2002-12-27
HUP0303758A3 (en) 2009-08-28
EP1337529A2 (fr) 2003-08-27
PT1337529E (pt) 2006-12-29
CZ20031316A3 (cs) 2003-10-15
AR034006A1 (es) 2004-01-21
PL363004A1 (en) 2004-11-15

Similar Documents

Publication Publication Date Title
DK1337529T3 (da) Heterocyclylalkylpiperidinderivater, deres fremstilling og præparater indeholdende dem
DK1370550T3 (da) Quinolylpropylpiperidinderivater, deres fremstilling og præparater indeholdende dem
NO20024175D0 (no) Azetidinderivater, deres fremstilling og farmasöytiske forbindelser inneholdende de samme
DK1083171T3 (da) Pyrazolinderivater, deres fremstilling og anvendelse som medikamenter
NO20015156L (no) 5-pyridyl-1,3-azolforbindelser, deres fremstilling og anvendelse
NO20014013D0 (no) 16-halogenepotilonderivater, fremgangsmater for fremstilling av dem og deres farmasoytiske anvendelse
NO20014603D0 (no) Tienopyrimidinforbindelser, deres fremstilling og anvendelse
DK1112251T3 (da) Azetidinderivater, deres fremstilling og medikamenter indeholdende disse derivater
NO20012567D0 (no) Azepinoindolderivater, fremstilling og anvendelse derav
NO20005146D0 (no) Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter
DK1095025T3 (da) Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler
NO20025357L (no) Antranylamider og deres anvendelse som legemidler
DK1073672T3 (da) Antipicornavirale forbindelser, deres fremstilling og anvendelse
DK1161434T3 (da) Pyridopyranoazepinderivater, deres fremstilling og terapeutiske anvendelse
NO20031838D0 (no) Benzokazinonderivater, deres fremstilling og anvendelse
DK1043307T3 (da) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
NO20023146D0 (no) Substituerte fenyl-piperazinderivater, deres fremstilling og anvendelse
NO20016247D0 (no) Streptograminderivater, deres fremstilling og preparater inneholdende derivatene
DK1228039T3 (da) N-guanidinoalkylamider, deres fremstilling, deres anvendelse og farmaceutiske præparater, der omfatter dem
DK1210348T3 (da) Naphthyridinderivater, fremgangsmåde til deres fremstilling, deres anvendelse og farmaceutiske præparater omfattende dem
NO20024107L (no) Tienopyridin derivater, deres fremstilling og anvendelse
NO20010469D0 (no) Antidiabetiske piperazinderivater, fremgangsmåter for deres fremstilling og preparater inneholdende dem
NO20025209L (no) Cyklipostiner, deres fremstilling og anvendelse
NO20006479D0 (no) Tienopyridinforbindelser, deres fremstilling og anvendelse
NO20000066D0 (no) 6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasoeytiske anvendelse